SCHEMBL24074358

SCHEMBL24074358

CCNc1cccc(C)c1C(=O)Nc1ncc(N=O)s1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 2/20 0.44
▸ STAT3 P40763 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ TSHR P16473 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ LCK P06239 2/20 0.37
▸ NPC1 O15118 5/20 0.37
▸ RAB9A P51151 5/20 0.37
▸ PKM P14618 2/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ STIM1 Q13586 1/20 0.36
▸ ORAI1 Q96D31 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ SCD O00767 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24073978 0.86 ALDH1A1 (0.40) ALDH1A1TSHRSMN1; SMN2NPC1RAB9A
SCHEMBL24073696 0.84 MAPK14 (0.46) MAPK14STAT3ALDH1A1TSHRSMN1; SMN2
SCHEMBL24073657 0.83 MAPK14 (0.47) MAPK14STAT3ALDH1A1TSHRSMN1; SMN2
SCHEMBL24072390 0.83 JAK2 (0.47) STAT3ALDH1A1TSHRSMN1; SMN2NPC1
SCHEMBL24073996 0.82 STAT3 (0.44) MAPK14STAT3SMN1; SMN2LCKNPC1
SCHEMBL27136854 0.82 ALDH1A1 (0.43) STAT3ALDH1A1TSHRSMN1; SMN2NPC1
SCHEMBL25063038 0.81 STAT3 (0.65) STAT3ALDH1A1TSHRSMN1; SMN2NPC1
SCHEMBL30142828 0.81 STAT3 (0.65) STAT3ALDH1A1TSHRSMN1; SMN2NPC1
SCHEMBL24073995 0.78 NPC1 (0.46) STAT3ALDH1A1TSHRSMN1; SMN2LCK
SCHEMBL24074429 0.76 RAB9A (0.52) STAT3ALDH1A1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
WO-2021239117-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI) , INC. (CN) 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 MAPK14 3714/4885STAT3 3224/4885ALDH1A1 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback